We assessed the protein expression level of the TAM receptor Axl and its ligand Gas6 in primary HNSCC tumor samples derived from a single center retrospective cohort of patients treated for HNSCC with curative intent in a tissue microarray format. This evidence concerns the gene AXL and head and neck squamous cell carcinoma.